<DOC>
	<DOC>NCT00103818</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of MK0928 for insomnia (a sleep disorder).</brief_summary>
	<brief_title>An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>Adult outpatients who are between the ages of 18 and 64 Adults who do not have a diagnosis of insomnia (a sleep disorder)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>